Clinical trials
Anemia trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
123 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 2 |
| 2004 | 11 |
| 2005 | 5 |
| 2006 | 9 |
| 2007 | 5 |
| 2008 | 2 |
| 2009 | 6 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 7 |
| 2014 | 11 |
| 2015 | 5 |
| 2016 | 8 |
| 2017 | 6 |
| 2018 | 8 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 11 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 85 |
| Terminated | 15 |
| Active, not recruiting | 8 |
| Recruiting | 8 |
| Unknown status | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 10 |
| GlaxoSmithKline | 9 |
| Affymax | 8 |
| Novartis Pharmaceuticals | 7 |
| Celgene | 6 |
| Takeda | 6 |
| Agios Pharmaceuticals, Inc. | 4 |
| Amgen | 4 |
| Bayer | 4 |
| Akebia Therapeutics | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia | 123 |
| Renal Insufficiency, Chronic | 30 |
| Kidney Failure, Chronic | 16 |
| Anemia, Iron-Deficiency | 11 |
| Myelodysplastic Syndromes | 10 |
| Hematologic Diseases | 9 |
| Primary Myelofibrosis | 9 |
| Iron Deficiencies | 8 |
| Anemia, Sickle Cell | 7 |
| Renal Insufficiency | 6 |
Trials
Showing 1 to 25 of 123. Each trial links to its page on Pharma Observatory.
23 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.